Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI) -- Ignore unavailable to you. Want to Upgrade?

To: W Shakespeare who wrote (350)	12/6/1999 5:43:00 PM
From: MGV	Read Replies (2) \| Respond to of 413

1.) TLCV's earnings shortfall announcement. Different model, different markets. Added LVCI today. 2.) A decision in the Visx v. Nidek case. Due out any minute. I expect VISX to win convincingly although a VISX loss probably would be perceived as beneficial to the centers. A VISX win should be neutral to the centers. I think the linkage of the ITC decision with the centers will be the impact on the license agreements VISX negotiates with LASE and BOL. 3.) LVCI's November procedure numbers. I look for a blowout. However, giving the stupidity of the investors in the sector, I doubt whether it will push the stock up much. Klobnak seemed to telegraph this. I too expect the procedure unit growth to be good. 4.) Idiot analyst downgrades. Prudential has been the only one to be consistent. Personally, I like the analysts, they add to the pricing inefficiency. ; )